Volpara (ASX:VHT) share price receives huge takeover boost
The Volpara Health Technologies Ltd (ASX:VHT) share price is in focus after agreeing to a huge takeover deal.
The Volpara Health Technologies Ltd (ASX:VHT) share price is in focus after agreeing to a huge takeover deal.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.31% to 7,257.80.
Luke Laretive of Seneca Financial Solutions highlights 3 significant ASX shares, namely, MMA Offshore Ltd (ASX: MRM), RPMGlobal Holdings Ltd (ASX: RUL), and Life360 Inc (ASX: 360), that upgraded earnings during November. Are these share prices a buy today?
The Sigma Healthcare Ltd (ASX:SIG) share price has jumped 36% after returning to the ASX. Chemist Warehouse is planning to list.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 36.3 points, or 0.5 per cent, to 7,235.3 points at the close. The broader All Ordinaries (INDEXASX: XAO) rose 36.2 points, or 0.5 per cent, to 7,446.4.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.50% to 7,235.30.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index ending the session 4.1 points to the good, at 7,199, while the broader All Ordinaries (INDEXASX: XAO) edged 4.6 points into the green, to 7,410.2.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.057% to 7,199.00.
Both local benchmarks finished the week on a positive note, with the All Ordinaries (INDEXASX: XAO) and S&P/ASX 200 (INDEXASX: XJO) gaining 0.3 per cent.
The Volpara Health Technologies Ltd (ASX:VHT) share price is in focus after agreeing to a huge takeover deal.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.31% to 7,257.80.
Luke Laretive of Seneca Financial Solutions highlights 3 significant ASX shares, namely, MMA Offshore Ltd (ASX: MRM), RPMGlobal Holdings Ltd (ASX: RUL), and Life360 Inc (ASX: 360), that upgraded earnings during November. Are these share prices a buy today?
The Sigma Healthcare Ltd (ASX:SIG) share price has jumped 36% after returning to the ASX. Chemist Warehouse is planning to list.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 36.3 points, or 0.5 per cent, to 7,235.3 points at the close. The broader All Ordinaries (INDEXASX: XAO) rose 36.2 points, or 0.5 per cent, to 7,446.4.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.50% to 7,235.30.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index ending the session 4.1 points to the good, at 7,199, while the broader All Ordinaries (INDEXASX: XAO) edged 4.6 points into the green, to 7,410.2.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.057% to 7,199.00.
Both local benchmarks finished the week on a positive note, with the All Ordinaries (INDEXASX: XAO) and S&P/ASX 200 (INDEXASX: XJO) gaining 0.3 per cent.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024